Why is Ind-Swift Labs. falling/rising?

As of 25-Jun, Ind-Swift Laboratories Ltd is currently priced at 108.51, reflecting an increase of 0.89 (0.83%). The stock has been gaining for the last two days, with a total return of 2.44% during this period. It is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend. Additionally, there has been a significant rise in investor participation, with delivery volume increasing by 71.7% compared to the 5-day average. Despite a year-to-date decline of 1.08% and a one-year drop of 9.23%, the stock's recent performance has been bolstered by a 50.71% increase over the past month, suggesting a recovery phase. However, the company faces challenges such as operating losses and a high Debt to EBITDA ratio, which may weigh on long-term investor sentiment.
In the broader market context, Ind-Swift Laboratories Ltd has outperformed the benchmark Sensex in the short term, with a 1-week return of 4.82% compared to the Sensex's 1.61%. This indicates that while the stock has been experiencing a positive momentum recently, it has still underperformed over the past year relative to the broader market, which has seen a 6.02% increase. The increase in institutional investor participation, which has risen by 2.59% in the previous quarter, suggests a growing confidence among more sophisticated investors despite the company's recent negative financial results. Overall, while the stock is currently on an upward trajectory, its long-term fundamentals remain a concern, potentially impacting its future performance.